A CRISPR Clinical Trial Patient Discusses His Sickle Cell Journey

Sickle cell disease, a genetic disorder with serious implications, affects nearly 100,000 Americans, and the global estimate is in the millions. The only viable treatment was a bone marrow transplant for several years, but advances in CRISPR gene therapy have recently created avenues for optimism.

Learn more about this disease and the CRISPR clinical trial directly from Jimi Olaghere, one of the early trial patients who has experienced complete recovery from his symptoms so far.